BRAF Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition

JCO Precis Oncol. 2018:2:PO.18.00025. doi: 10.1200/PO.18.00025. Epub 2018 Jun 14.
No abstract available